论文部分内容阅读
目的研究并分析在急性缺血性脑卒中的临床治疗过程中采用丁苯酞治疗的临床治疗效果以及对患者的保护作用。方法 80例急性缺血性脑卒中患者,按治疗方法不同分成对照组和试验组,各40例。对照组采用常规综合治疗方法 ,试验组在对照组基础上给予丁苯酞胶囊治疗。对比分析两组患者的临床治疗效果并检测其血清中的超氧化物歧化酶(SOD)活性以及丙二醛(MDA)含量。结果治疗后,试验组患者的治疗总有效率、SOD活性高于对照组,MDA含量低于对照组,差异均有统计学意义(P<0.05)。结论在急性缺血性脑卒中患者的临床治疗过程中,采用丁苯酞治疗的效果十分明显,且对患者具有一定的保护作用,值得在临床广泛推广。
Objective To study and analyze the clinical efficacy of butylphthalide in the clinical treatment of acute ischemic stroke and its protective effect on patients. Methods Eighty patients with acute ischemic stroke were divided into control group and experimental group according to different treatment methods, 40 cases in each. The control group using conventional comprehensive treatment, the experimental group in the control group given butylphthalide capsule treatment. The clinical effects of two groups were compared and the serum superoxide dismutase (SOD) activity and malondialdehyde (MDA) content were measured. Results After treatment, the total effective rate of treatment, SOD activity in experimental group were higher than that in control group, and MDA content was lower than that in control group (P <0.05). Conclusions In the clinical treatment of patients with acute ischemic stroke, the effect of using butylphthalide is very obvious, and has certain protective effect on patients, which is worth widely popularized in clinic.